MXCT
MaxCyte Inc
1.20$
+1.7%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +95.7% | -27.6% | -8.0% | -21.7% | +6.5% | +19.5% | -18.1% | -19.7% | +6.9% | +32.2% | -24.7% | – | |
| – | +98.4% | -10.8% | +6.1% | +29.6% | +18.3% | -34.4% | +1.5% | -66.0% | +212.0% | +60.6% | -35.2% | – | |
| – | +95.4% | -29.5% | -10.0% | -30.3% | +2.8% | +38.7% | -21.4% | -9.7% | -9.9% | +24.2% | -20.8% | – | |
| – | -6.7% | +14.3% | -15.9% | -5.4% | -13.2% | +27.9% | +6.2% | -15.2% | -37.3% | +15.7% | +10.3% | – | |
| – | +18.6% | -12.2% | +7.5% | +1.4% | -7.0% | +18.3% | -5.2% | -25.7% | -8.7% | +8.8% | +21.7% | – | |
| – | +4.8% | +0.1% | -5.9% | -3.0% | -4.8% | +9.7% | +0.1% | -20.4% | -20.9% | -0.8% | +19.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.